Literature DB >> 6321752

Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization.

K Ikuta, S Ueda, S Kato, K Hirai.   

Abstract

By use of monoclonal antibodies cross-reactive with Marek's disease virus and herpesvirus of turkeys, three glycoproteins (for Marek's disease virus, gp115/110, gp63, and gp50; for herpesvirus of turkeys, gp115, gp62 and gp52) related to virus neutralization were identified. Immunization of chickens or rabbits with these glycoproteins purified by affinity chromatography resulted in production of neutralizing antibodies.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6321752      PMCID： PMC255568     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  16 in total

1.  Minor DNA homology between herpesvirus of turkey and Marek's disease virus?

Authors:  Y S Lee; A Tanaka; S Silver; M Smith; M Nonoyama
Journal:  Virology       Date:  1979-02       Impact factor: 3.616

2.  Studies of Marek's disease herpesvirus and turkey herpesvirus specific common antigen which stimulates the production of neutralizing antibodies.

Authors:  M Onuma; T Mikami; T T Hayashi; K Okada; Y Fujimoto
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

3.  No homology detectable between Marek's disease virus (MDV) DNA and herpesvirus of the turkey (HVT) DNA.

Authors:  C Kaschka-Dierich; G W Bornkamm; R Thomssen
Journal:  Med Microbiol Immunol       Date:  1979-01-24       Impact factor: 3.402

Review 4.  Use of staphylococcal protein A as an immunological reagent.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

5.  Properties of the common antigen associated with Marek's disease herpesvirus and turkey herpesvirus infections.

Authors:  M Onuma; T Mikami; T T Hayashi
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

6.  Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus.

Authors:  R L Witter; K Nazerian; H G Purchase; G H Burgoyne
Journal:  Am J Vet Res       Date:  1970-03       Impact factor: 1.156

7.  Purification and properties of the 'A' antigen associated with Marek's disease virus infections.

Authors:  L J Ross; P M Biggs; A A Newton
Journal:  J Gen Virol       Date:  1973-03       Impact factor: 3.891

8.  Monoclonal antibodies specific to and cross-reactive with Marek's disease virus and herpesvirus of turkeys.

Authors:  K Ikuta; H Honma; K Maotani; S Ueda; S Kato; K Hirai
Journal:  Biken J       Date:  1982-12

9.  Induction of virus-neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys.

Authors:  A P Wyn-Jones; O R Kaaden
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

10.  Immunofluorescence in the study of Marek's disease. I. Detection of antigen in cell culture and an antigenic comparison of eight isolates.

Authors:  H G Purchase
Journal:  J Virol       Date:  1969-06       Impact factor: 5.103
View more
  15 in total

1.  Bovine herpesvirus type 1 gp87 mediates both attachment of virions to susceptible cells and hemagglutination.

Authors:  K Okazaki; E Honda; T Minetoma; T Kumagai
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex.

Authors:  I Sithole; L F Lee; L F Velicer
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  Map location of homologous regions between Marek's disease virus and herpesvirus of turkey and the absence of detectable homology in the putative tumor-inducing gene.

Authors:  K Fukuchi; M Sudo; A Tanaka; M Nonoyama
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

5.  Identification with monoclonal antibodies of virus-specific DNA-binding proteins in the nuclei of cells infected with three serotypes of Marek's disease virus-related viruses.

Authors:  K Nakajima; K Ikuta; S Ueda; S Kato; K Hirai
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

6.  Monospecific antibodies to Marek's disease virus antigen B dimer (200 kDa) and monomer (130 and 60 kDa) glycoproteins neutralize virus infectivity and detect the antigen B proteins in infected cell membranes.

Authors:  I Davidson; Y Becker; M Malkinson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Similarities and dissimilarities in the structure and expression of viral genomes of various virus strains immunologically related to Marek's disease virus.

Authors:  K Hirai; K Nakajima; K Ikuta; R Kirisawa; Y Kawakami; T Mikami; S Kato
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

8.  Antigen B of the vaccine strains of Marek's disease virus and herpesvirus of turkeys presents heat-labile group and serotype specific epitopes.

Authors:  M Malkinson; I Davidson; Y Becker
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Expression of a novel Marek's disease virus type 1 (MDV1)-specific protein p40 in insect cells by a baculovirus vector and in chick embryo fibroblasts infected with MDV1.

Authors:  T Urakawa; M Sakaguchi; M Yamamoto; G S Zhu; K Hirai
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.

Authors:  Shane C Burgess; T Fred Davison
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.